SMi's 9th Annual Pharmaceutical Microbiology Conference

SMi's 9th Annual Pharmaceutical Microbiology Conference is organized by SMi Group Ltd and will be held from Jan 20 - 21, 2020 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.

Who Should Attend:
Allergan Biologics Ltd; Allergy Therapeutics; Allergy Therapeutics UK; AllergyTherapeutics; AstraZeneca; Atalmedial; Baxter Healthcare Ltd; Biomerieux; bioMerieux UK Limited; Boehringer Ingelheim; BPL; British America Tobacco; Cancer Research UK; Cell and Gene Therapy Catapult; Ceutiqus; CGT - Catapult ; CGT (Cell & Gene Therapy Catapult) ; ChargePoint Technology; Charles River; Copan Italia SpA; Dupont De Nemours (Luxembourg) S A; DuPont de Nemours Luxembourg sarl; Fresenius Kabi; Fresenius Kabi UK Ltd; Fujifilm Wako Chemicals USA Corp; Genzyme Geel; Greiner Bio-One; GSK; GSK Vaccines; International Serum Industry Association; Ipsen; Kings College London; MeiraGTx; Mettler Toledo; Mettler Toledo Ltd; Mettler-Toledo Ltd; Mettler-Toledo Thornton; MHRA; Microrite, Inc.; Novo Nordisk; Oak Zone Biotech; Pharmaceutical and Healthcare Sciences Society; Roche Diagnostics Deutschland GmbH; Royal Free Hospital; RSSL; Sanofi; Sanofi Pasteur; Steris Corporation; Synthon Chile; TEVA Runcorn; Teva UK Ltd; The LFB Group; University of Southampton; University of Veterinary Medicine Vienna; zac vventures inc;

Conference Overview:
Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.

At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.

Highlights for 2020:
• Discuss the regulatory expectations and supportive guidance on bio-contamination control and monitoring in aseptic manufacturing of sterile products from PHSS
• Gain valuable insight from key opinion leaders in a panel discussion on the impact of the Annex 1 revisions on pharmaceutical microbiology
• Examine the common myths and urban legends in the pharmaceutical industry related to contamination control from STERIS
• Explore container closure integrity and controls strategies ensuring product sterility from AstraZeneca
• Revisit the role of the Official Medicines Control Laboratories as the GMP back up from Infarmed IP

Workshop:
Pharmaceutical Microbiology Workshop Day
Venue: Copthorne Tara Hotel, London, United Kingdom
22nd January 2020

Additional details will be posted as soon as information is available.